Martek Biosciences

Daesang Corp follows in Martek Biosciences and Ocean Nutrition Canada's footsteps with Schizochytrium sp. microalgae oil for the EU. © iStock.com / pichet_w

Korean firm seeks EU access for novel algal DHA oil

By Annie Harrison-Dunn

The South Korean company Daesang Corp has applied for novel food approval for its DHA-rich algal oil, claiming ‘substantial equivalence’ to an already-approved oil produced by DSM-owned Martek Biosciences.

Ocean Nutrition Canada seeks algal omega-3 oil approval in EU

Ocean Nutrition Canada seeks algal omega-3 oil approval in EU

By Shane Starling

Ocean Nutrition Canada has applied to have an omega-3 algal oil approved under European Union novel foods regulations – stating it is ‘substantially equivalent’ to an existing approved oil manufactured by Martek-DSM.

DHA omega-3 may offer sports protection

Dispatches from Vitafoods Europe 2011

DHA omega-3 may offer sports protection

By Nathan Gray

DHA (docosahexaenoic acid) is the critical omega-3 fatty acid in the brain and research backs its ability to boost brain function. But can it slow the onset of Alzheimer’s Disease and help protect sportspeople against concussion?

DSM on Vitatene, Martek and its investment “shortlist”

Disptaches from Vitafoods Europe 2011

DSM on Vitatene, Martek and its investment “shortlist”

By Shane Starling

DSM’s head of global marketing in human nutrition and health, Gareth Barker, explains why it has bought a carotenoid supplier (approval permitting), how the Martek acquisition is progressing, and why the company is not finished spending yet.

DSM's €24/share offer for Martek remains open until February 21, 2010

DSM’s Greenback formalises €829m Martek tender

By Shane Starling

Greenback Acquisition Corporation, a wholly-owned Royal DSM subsidiary, has begun the formal tender for Martek Biosciences, which DSM announced it was buying for €829m ($1.087bn) last month.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers